Presentation slides and video from the 2017 Advances in Cancer Immunotherapy™ - San Francisco, CA held on May 6, 2017 are available here.Program Organizers
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of:
Meeting: Advances in Cancer Immunotherapy™- San Francisco, CA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy; Presentation: Basic Principles of Cancer Immunotherapy; Presenter: Robert H. Pierce, MD – Fred Hutchinson Cancer Research Center; Date: May 6, 201700:39:54
Meeting: Advances in Cancer Immunotherapy™- San Francisco, CA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy; Presentation: Immunotherapy for the Treatment of Melanoma; Presenter: Adil Daud, MD – University of California, San Francisco; Date: May 6, 201700:23:30
Meeting: Advances in Cancer Immunotherapy™- San Francisco, CA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy; Presentation: Immunotherapy for the Treatment of Lung Cancer; Presenter: Matthew Gubens, MD, MS – University of California, San Francisco; Date: May 6, 201700:23:04
Meeting: Advances in Cancer Immunotherapy™- San Francisco, CA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy; Presentation: Immunotherapy for the Treatment of Genitourinary Cancers; Presenter: Terence Friedlander, MD – University of California, San Francisco; Date: May 6, 201700:23:31
Meeting: Advances in Cancer Immunotherapy™- San Francisco, CA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy; Presentation: Immunotherapy for the Treatment of Hematologic Malignancies; Presenter: Charalambos Babis Andreadis, MD, MSCE – University of California, San Francisco; Date: May 6, 201700:25:50
Meeting: Advances in Cancer Immunotherapy™- San Francisco, CA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy; Presentation: Immunotherapy for the Treatment of Head and Neck Cancers; Presenter: Alain Algazi, MD – University of California, San Francisco; Date: May 6, 201700:22:49
Meeting: Advances in Cancer Immunotherapy™- San Francisco, CA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session II: Overcoming Barriers to Incorporating Immunotherapy Into Community Practice; Presentation: Effective Practices for Incorporating Immunotherapy Into Hospital Operations; Presenter: Julie Kennerly, PharmD, MS, MHA, BCPS – Ohio State University Comprehensive Cancer Center; Date: May 6, 201700:30:29
Meeting: Advances in Cancer Immunotherapy™- San Francisco, CA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session II: Overcoming Barriers to Incorporating Immunotherapy Into Community Practice; Presentation: Coverage and Reimbursement Challenges and Strategies; Presenter: Julie Kennerly, PharmD, MS, MHA, BCPS – Ohio State University Comprehensive Cancer Center; Date: May 6, 201700:24:47
Meeting: Advances in Cancer Immunotherapy™- San Francisco, CA; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Mechanisms of Immune-Related Adverse Events; Presenter: Mehrdad Matloubian, MD, PhD – University of California, San Francisco; Date: May 6, 201700:24:15
Meeting: Advances in Cancer Immunotherapy™- San Francisco, CA; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Nursing Perspective on irAEs: Patient Education, Monitoring and Management; Presenter: Michael Buljan, NP – University of California, San Francisco; Date: May 6, 201700:39:48
Meeting: Advances in Cancer Immunotherapy™- San Francisco, CA; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Management and Mitigation of irAEs for Immunotherapy Prescribers; Presenter: Mary Nakamura, MD – University of California, San Francisco; Date: May 6, 201700:36:35
Meeting: Advances in Cancer Immunotherapy™- San Francisco, CA; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Identification and Management of Immune-Related Adverse Events in the Emergency Setting; Presenter: Thomas Tobin, MD, MBA, FAAEM – American Academy of Emergency Medicine Board of Directors; Date: May 6, 201700:29:13
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us